Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Galenica increases shareholding in Redcare Pharmacy to 10%


Galenica AG / Key word(s): Investment
Galenica increases shareholding in Redcare Pharmacy to 10%

22.07.2024 / 18:11 CET/CEST


Press release

Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V.

As part of the strategic partnership between Galenica and Redcare Pharmacy through the establishment of the joint venture Mediservice, Galenica has held a 7.9% stake in Redcare Pharmacy since May 2023. By increasing its participation, Galenica is strengthening its cooperation with Redcare Pharmacy, which has developed positively since the partnership was established. Galenica believes in the successful further development of Europe’s leading online pharmacy and intends to maintain its investment in Redcare Pharmacy in the long term. By increasing its stake to more than 10%, Galenica will be able to benefit from tax-free dividends and capital gains in the future. There are no plans to further increase the investment.

Dates for the diary

6 August 2024 Publication of Galenica Group half-year results 2024
24 October 2024 Galenica Group sales update
23 January 2025 Publication 2024 sales of the Galenica Group

 

For further information, please contact:

 

Media Relations:
E-Mail: [email protected]
Tel. +41 58 852 85 17
Investor Relations:
E-Mail: [email protected]
Tel. +41 58 852 85 31

Welcome to the Galenica network!
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market. We offer fully integrated solutions both for customers and patients as well as for pharmacies, drugstores, medical practices, hospitals, retirement and nursing homes, home care providers, wholesalers, pharmaceutical companies, health insurance funds and other partners.
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information concerning Galenica can be found at www.galenica.com.



End of Media Release


Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: +41 058 852 81 11
E-mail: info@galenica.com
Internet: https://www.galenica.com
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 1951159

 
End of News EQS News Service

1951159  22.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1951159&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments